688187.SH_Providing professional financial news and data related to 688187.SH, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Finance
Zhongtai Futures (01461.HK): Positive Profit Alert, Interim Net Profit Attributable to Parent Expected to Rise 190% to 210%
Finance
InnoCare Pharma Limited(09969.HK): Phase III Registrational Trial of Soficitinib (ICP-332) for Moderate-to-Severe Atopic Dermatitis Meets Primary Endpoint Successfully
Finance
Cinda International Holdings (00111.HK): Profit Forecast, Interim Consolidated Net Profit Expected at HK$32 Million to HK$38 Million
Finance
Beijing Enterprises Holdings (00392.HK): Proposed Issuance of Sci-Tech Innovation Corporate Bonds Capped at RMB 1 Billion
Research
Daily Report on Hong Kong-Listed LLM Concept Stocks (July 15, 2026)
Finance
Haixi Pharmaceuticals (02637.HK): Non-executive Director Wang Xinkun Resigns; Chen Tingze Nominated as Candidate for Executive Director
Finance
China Medical System Holdings(00867.HK): Self-Developed Complement Factor B Inhibitor CMS-D017 Approved for Clinical Trials in AMD Indication
Finance
Fosun Pharmaceutical (02196.HK): Injection FXR0906 Approved for Clinical Trials
Finance
Hopefluent Group (00733.HK): Non-executive Director Li Fuqiang Resigns; Wang Jie Appointed
Finance
Ascletis Pharma(01672.HK): Fixed-Dose Combination of GIPR Agonist ASC48 and GLP-1R Agonist ASC30 Selected for Clinical Development

Scan QR Code

Download App